Atypical antipsychotic-like effect of AMPA receptor antagonists in the rat

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

1997 • 1,743 citations

IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.

1965 • 348 citations

Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

1982 • 238 citations

Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats

1992 • 140 citations

MK-801-induced stereotypy and its antagonism by neuroleptic drugs

1990 • 138 citations

Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens

1998 • 129 citations

Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens

1996 • 125 citations

Introduction to Medical Statistics.

1990 • 124 citations

Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

1992 • 122 citations

Suppression of conditioned avoidance behavior by the local application of (−)sulpiride into the ventral, but not the dorsal, striatum of the rat

1990 • 113 citations

Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization

1993 • 111 citations

Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: A comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission

1986 • 102 citations

Pharmacodynamic basis for the use of chlorpromazine in psychiatry.

1956 • 72 citations

In vitro and in vivo antagonism of AMPA receptor activation by (3s,4ar,6r,8ar)-6-[2-(1(2)h-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid

1995 • 65 citations

Long‐term clinical and Social outcome studies in schizophrenia in relation to the cognitive and emotional side effects of antipsychotic drugs

1994 • 51 citations

Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats

1995 • 43 citations

Effects of AMPA receptor antagonists on dopamine-mediated behaviors in mice

1998 • 35 citations

Effects of chlorpromazine and secobarbital on avoidance and escape behavior.

1958 • 25 citations

Clozapine improves dizocilpine-induced delayed alternation impairment in rats

1993 • 24 citations

Interactions between Catecholamines and Serotonin: Relevance to the Pharmacology of Schizophrenia

1997 • 14 citations

Antipsychotic-like effect of the AMPA receptor antagonist LY326325 as indicated by suppression of conditioned avoidance response in the rat

1999 • 11 citations

Cited By (0)

Loading...